First-pass extracted concept

PROWESS

Candidate: concept label2 source documents0 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

Recombinant human protein C Worldwide Evaluation in Severe Sepsis

Extracted Explainers

What the tool is doing

PROWESS is identified in the web research summary as the named trial/program associated with activated protein C evidence relevant to the guideline.

Source 1DOI PubMed

What problem it solves

It provides a recognizable evidence anchor for one recommendation domain in severe sepsis management.

Source 1DOI PubMed

What it does not solve

The provided source text does not state outcomes, eligibility, or limitations of the PROWESS study.

Source 1DOI PubMed

Alternatives

No direct alternative trial program is explicitly contrasted in the provided source text.

Source 1DOI PubMed

Evidence Snippets

Related component/tool names are only included where explicit in discovered sources, notably Surviving Sepsis Campaign, Early Goal-Directed Therapy, PROWESS, and TRICC.

Evidence 1Source 1DOI PubMedprovenance

Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group.

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1primary paper2007Intensive Care MedicineDOI PubMed

1 evidence snippet 0 linked claims

Source 2primary paper2001New England Journal of MedicineDOI PubMed

1 evidence snippet 0 linked claims

Linked Claims

No linked claims captured.